SecBot SecBot
8-K ·Filed Jun 12, 2026

ABEO

ABEONA THERAPEUTICS INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago SEC0001493152-26-028369
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

This is a routine board departure with no trading implications. Monitor for any future board composition changes or patterns, but no action is warranted based on this filing alone.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$5.53
T+0 close · Jun 12, 2026 · via day close
Latest settled
+26.22%
T+20 · $6.98
Vs SPY
+24.44%
α at T+20
Next horizon
T+60
due 2mo ago
  1. T+0 · Jun 12 $5.53entry
  2. T+1 · 5mo ago +2.53%α +0.77% · $5.67
  3. T+5 · 5mo ago +4.34%α +3.67% · $5.77
  4. T+20 · 4mo ago +26.22%α +24.44% · $6.98
  5. T+60 · due 2mo ago Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Board member Michael Amoroso resigned from Abeona Therapeutics' Board of Directors and its Nominating and Corporate Governance Committee effective June 11, 2026, citing personal reasons. The filing explicitly states the resignation was not due to any disagreement with the company. This is a routine director departure with no operational or financial impact.

Key Facts

  • Michael Amoroso resigned from the Board of Directors effective June 11, 2026
  • Resignation also covered his role on the Nominating and Corporate Governance Committee
  • Resignation was for personal reasons, not due to any disagreement with the company
  • No replacement was named in the filing
  • No other officers or directors were impacted

Financial Impact

No financial impact

Risk Factors

  • Potential governance concerns if multiple board departures occur in a short period, though none indicated here

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-028369
Document: 0001493152-26-028369-index-headers.html0001493152-26-028369
Document: 0001493152-26-028369-index.html0001493152-26-028369
Document: 0001493152-26-028369.txt0001493152-26-028369

Track record

29 reports on ABEO

Performance horizon

4 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +15.24% at T+20 after the Sep 29, 2026 report. 4 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 4/10 Entry $2.59 Now $2.60 +0.39% settles Nov 18
  2. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $2.30 Now $2.60 +13.04% settles Nov 17
  3. Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $2.29 to $2.42 Now $2.60 +13.54% ▲ +5.68% +6.04% vs SPY
  4. Nov 9, 20267d ago Press Release Neutral 5/10 Entry $2.54 to $2.46 Now $2.60 +2.36% ▼ −3.35% −2.98% vs SPY
  5. Nov 9, 20267d ago 8-K Bearish 6/10 Entry $2.54 to $2.46 Now $2.60 −2.36% ▲ +3.35% +2.98% vs SPY
  6. Nov 9, 20267d ago Press Release Mixed 6/10 Entry $2.54 to $2.46 Now $2.60 +2.36% ▼ −3.35% −2.98% vs SPY
  7. Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $4.17 to $2.54 Now $2.60 −37.65% ▼ −39.09% −41.46% vs SPY
  8. Oct 23, 202624d ago SC 13D Bullish 6/10 Entry $4.40 to $4.31 Now $2.60 −40.91% ▼ −2.05% −2.76% vs SPY
  9. Sep 29, 20266w ago Insider Cluster Bearish 4/10 Entry $5.25 to $5.01 Now $2.60 +50.48% ▲ +4.57% +4.75% vs SPY
  10. Sep 18, 20268w ago Press Release Bullish 6/10 Entry $5.57 to $5.67 Now $2.60 −53.32% ▲ +1.80% +0.24% vs SPY
Showing 10 of 29

US Market Status

Market Closed · Opens in 8h 4m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 12, 2026